Gemcitabine Hydrochloride, Rituximab, Oxaliplatin, and Lenalidomide in Treating Patients With Relapsed or Refractory, Aggressive Non-Hodgkin Lymphoma
- Status
- UNKNOWN
- Phase
- PHASE2
Clinical Trials Related to Oxaliplatin
Related studies linked through entity extraction aliases.
Altered Chemotherapy Sequencing During Neoadjuvant Therapy for Patients With Stage II or III Rectal Adenocarcinoma
- Status
- WITHDRAWN
- Phase
- PHASE1/PHASE2
Taxotere®, Eloxatin® and Xeloda® (TEX) in Combination With Herceptin® as Treatment for HER2 Positive Non-resectable Cancer
- Status
- COMPLETED
- Phase
- NA
First Line Treatment of Metastatic Colorectal Cancer With mFOLFOX6 in Combination With Regorafenib
- Status
- COMPLETED
- Phase
- PHASE2
Combination Chemotherapy and Cetuximab or Bevacizumab in Treating Patients With Metastatic Colorectal Cancer
- Status
- TERMINATED
- Phase
- NA
Combination Chemotherapy Plus Bevacizumab With or Without Oxaliplatin in Treating Older Patients With Metastatic Colorectal Cancer
- Status
- TERMINATED
- Phase
- PHASE3
Combination Chemotherapy and Bevacizumab With or Without RO4929097 in Treating Patients With Metastatic Colorectal Cancer
- Status
- WITHDRAWN
- Phase
- PHASE2
Oxaliplatin, Leucovorin, and Fluorouracil Before and After Radiation Therapy and Surgery in Treating Patients With Rectal Cancer That Can Be Removed by Surgery
- Status
- COMPLETED
- Phase
- PHASE2
Study of Oxaliplatin and Sorafenib Combination to Treat Gastric Cancer Relapsed After a Cisplatin Based Treatment
- Status
- COMPLETED
- Phase
- PHASE2
A Study of Ramucirumab in Participants With Gastric, Esophageal, and Gastroesophageal Cancer
- Status
- COMPLETED
- Phase
- PHASE2
Veliparib, Oxaliplatin, and Capecitabine in Treating Patients With Advanced Solid Tumors
- Status
- TERMINATED
- Phase
- PHASE1
Everolimus and Combination Chemotherapy in Treating Patients With Metastatic Stomach or Esophageal Cancer
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2
Cediranib Maleate and Combination Chemotherapy in Treating Patients With Advanced Biliary Cancers
- Status
- TERMINATED
- Phase
- PHASE2
A Trial to Compare Oxaliplatin, Folinic Acid (FA) and 5-Fluorouracil (5FU) Combination Chemotherapy (FOLFOX-4) With or Without Cetuximab in the 1st Line Treatment of Metastatic Colorectal Cancer (mCRC) in Chinese Rat Sarcoma Viral Oncogene Homolog (RAS) Wild-type Patients
- Status
- COMPLETED
- Phase
- PHASE3
Preoperative S-1/OHP With Radiation Therapy for Low-lying Rectal Carcinoma in Neo-adjuvant Setting
- Status
- UNKNOWN
- Phase
- PHASE1/PHASE2
FOLFOXIRI Plus Panitumumab Patients With Metastatic KRAS Wild-Type Colorectal Cancer With Liver Metastases Only
- Status
- COMPLETED
- Phase
- PHASE2
Erbitux Study of CPT11, Oxaliplatin, UFToral Targeted Therapy
- Status
- COMPLETED
- Phase
- PHASE2
Study for Therapy of Locally Advanced or Metastatic Non Small Cell Lung Cancer (NSCLC) With Cisplatin / Docetaxel or Oxaliplatin / Docetaxel
- Status
- COMPLETED
- Phase
- PHASE2
5-FU, Leucovorin, Oxaliplatin and Docetaxel (FLOT) Versus Epirubicin, Cisplatin and 5-FU (ECF) in Patients With Locally Advanced, Resectable Gastric Cancer
- Status
- COMPLETED
- Phase
- PHASE2/PHASE3
Hepatic Arterial Infusion Oxaliplatin, Capecitabine With or Without Bevacizumab
- Status
- COMPLETED
- Phase
- PHASE1